---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-004220"
form_type: "8-K"
ticker: "RNLXY"
cik: "0001811115"
company_name: "Renalytix plc"
filed_at: "2025-01-16T23:59:59+00:00"
generated_at: "2026-05-28T00:14:04.087974+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Renalytix reverts to foreign private issuer SEC filing status effective Jan 1, 2025

## Summary
- Company determined it qualifies as FPI as of Dec 31, 2024; will cease domestic issuer filings.
- Effective Jan 1, 2025, Renalytix will file periodic reports using FPI forms.
- Company had previously been an FPI but filed as domestic since July 1, 2023.
- Change may reduce SEC reporting burden (e.g., no quarterly 10-Q, different GAAP allowed).

## SEC filing metadata
- accession: 0001213900-25-004220
- form_type: 8-K
- ticker: RNLXY
- cik: 0001811115
- company_name: Renalytix plc
- filed_at: 2025-01-16T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811115/000121390025004220/0001213900-25-004220-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811115/000121390025004220/ea0227953-8k_renalytix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-004220
- JSON: https://secwatch.observer/filing/0001213900-25-004220.json
- Plain text: https://secwatch.observer/filing/0001213900-25-004220.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.